We found that CDKN1B, FAS, FOS, FOXO1, GABARAPL1, HDAC1, NFKB1, PEX3, PPP1R15A, and SIRT2 were all significantly lowly expressed in ovarian cancer than normal specimens (Figures 8A–J). This evidence concerns the gene FAS and ovarian cancer.